2021 European Guideline on the Management of Proctitis, Proctocolitis and Enteritis Caused by Sexually Transmissible Pathogens
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Onset of Clinical Manifestations in Inflammatory Bowel Disease Patients
AG-2018-65 ORIGINAL ARTICLE dx.doi.org/10.1590/S0004-2803.201800000-73 The onset of clinical manifestations in inflammatory bowel disease patients Viviane Gomes NÓBREGA1, Isaac Neri de Novais SILVA1, Beatriz Silva BRITO1, Juliana SILVA1, Maria Carolina Martins da SILVA1 and Genoile Oliveira SANTANA2,3 Received 29/10/2017 Accepted 10/8/2018 ABSTRACT – Background – The diagnosis of inflammatory bowel disease is often delayed because of the lack of an ability to recognize its major clinical manifestations. Objective – Our study aimed to describe the onset of clinical manifestations in inflammatory bowel disease patients. Methods – A cross-sec- tional study. Investigators obtained data from interviews and the medical records of inflammatory bowel disease patients from a reference centre located in Brazil. Results – A total of 306 patients were included. The mean time between onset of symptoms and diagnosis was 28 months for Crohn’s disease and 19 months for ulcerative colitis. The main clinical manifestations in Crohn’s disease patients were weight loss, abdominal pain, diarrhoea and asthenia. The most relevant symptoms in ulcerative colitis patients were blood in the stool, faecal urgency, diarrhoea, mucus in the stool, weight loss, abdominal pain and asthenia. It was observed that weight loss, abdominal pain and distension, asthenia, appetite loss, anaemia, insomnia, fever, nausea, perianal disease, extraintestinal manifestation, oral thrush, vomiting and abdominal mass were more frequent in Crohn’s patients than in ulcerative colitis patients. The frequencies of urgency, faecal incontinence, faeces with mucus and blood, tenesmus and constipation were higher in ulcerative colitis patients than in Crohn’s disease patients. -
Gastroenterology and the Elderly
3 Gastroenterology and the Elderly Thomas W. Sheehy 3.1. Esophagus 3.1.1. Dysphagia Esophageal disorders, such as esophageal motility disorders, infections, tumors, and other diseases, are common in the elderly. In the elderly, dysphagia usually implies organic disease. There are two types: (1) pre-esophageal and (2) esophageal. Both are further subdivided into motor (neuromuscular) or structural (intrinsic and extrinsic) lesions.! 3.1.2. Pre-esophageal Dysphagia Pre-esophageal dysphagia (PED) usually implies neuromuscular disease and may be caused by pseudobular palsy, multiple sclerosis, amy trophic lateral scle rosis, Parkinson's disease, bulbar poliomyelitis, lesions of the glossopharyngeal nerve, myasthenia gravis, and muscular dystrophies. Since PED is due to inability to initiate the swallowing mechanism, food cannot escape from the oropharynx into the esophagus. Such patients usually have more difficulty swallowing liquid THOMAS W. SHEEHY • The University of Alabama in Birmingham, School of Medicine, Department of Medicine; and Medical Services, Veterans Administration Medical Center, Birming ham, Alabama 35233. 87 S. R. Gambert (ed.), Contemporary Geriatric Medicine © Plenum Publishing Corporation 1983 88 THOMAS W. SHEEHY than solids. They sputter or cough during attempts to swallow and often have nasal regurgitation or aspiration of food. 3.1.3. Dysfunction of the Cricopharyngeus Muscle In the elderly, this is one of the more common forms of PED.2 These patients have the sensation of an obstruction in their throat when they attempt to swallow. This is due to incoordination of the cricopharyngeus muscle. When this muscle fails to relax quickly enough during swallowing, food cannot pass freely into the esophagus. If the muscle relaxes promptly but closes too quickly, food is trapped as it attempts to enter the esophagus. -
Ulcerative Proctitis
Patient & Family Guide 2016 Ulcerative Proctitis www.nshealth.ca Ulcerative Proctitis What is Inflammatory Bowel Disease? Inflammatory bowel disease (IBD) is the general name for diseases that cause inflammation (swelling and irritation) in the intestines (“gut”). It includes the following: • Ulcerative proctitis • Crohn’s disease • Ulcerative colitis What are your questions? Please ask. We are here to help you. 1 What is ulcerative proctitis and how is it different from ulcerative colitis? Ulcerative proctitis (UP) is a type of ulcerative colitis (UC). UC is an inflammatory disease of the colon (large intestine or large bowel). The inner lining of the colon becomes inflamed and has ulcerations (sores). The entire large bowel is involved in UC. When only the lowest part of the colon is involved (the rectum, 15 to 20 cm from the anus), it is called ulcerative proctitis. 15-20 cm Rectum Large intestine (large bowel) 2 How is ulcerative proctitis diagnosed? • A test called a sigmoidoscopy will tell us if you have this problem. The doctor uses a special tube which bends and has a small light and camera on the end to look at the inside of your lower bowel and rectum. The tube is passed through the anus to the rectum and into the last 25 cm of the large bowel. • A biopsy (small piece of bowel tissue is taken) during the test and sent to the lab for study. • Most people do not find the test and biopsy uncomfortable and medicine to relax or make you sleepy is not usually needed. What are the symptoms of ulcerative proctitis? • Rectal bleeding and itching, passing mucus through the rectum, and feeling like you always need to pass stool (poop) even though your bowel is empty. -
Ulcerative Proctitis
Ulcerative Proctitis Ulcerative proctitis is a mild form of ulcerative colitis, a ulcerative proctitis are not at any greater risk for developing chronic inflammatory bowel disease (IBD) consisting of fine colorectal cancer than those without the disease. ulcerations in the inner mucosal lining of the large intestine that do not penetrate the bowel muscle wall. In this form of colitis, Diagnosis the inflammation begins at the rectum, and spreads no more Typically, the physician makes a diagnosis of ulcerative than about 20cm (~8″) into the colon. About 25-30% of people proctitis after taking the patient’s history, doing a general diagnosed with ulcerative colitis actually have this form of the examination, and performing a standard sigmoidoscopy. A disease. sigmoidoscope is an instrument with a tiny light and camera, The cause of ulcerative proctitis is undetermined but there inserted via the anus, which allows the physician to view the is considerable research evidence to suggest that interactions bowel lining. Small biopsies taken during the sigmoidoscopy between environmental factors, intestinal flora, immune may help rule out other possible causes of rectal inflammation. dysregulation, and genetic predisposition are responsible. It is Stool cultures may also aid in the diagnosis. X-rays are not unclear why the inflammation is limited to the rectum. There is a generally required, although at times they may be necessary to slightly increased risk for those who have a family member with assess the small intestine or other parts of the colon. the condition. Although there is a range of treatments to help ease symptoms Management and induce remission, there is no cure. -
CDHO Factsheet Ulcerative Colitis
Disease/Medical Condition ULCERATIVE COLITIS Date of Publication: June 14, 2013 (also referred to as “UC”, “idiopathic proctocolitis”, “pancolitis”, and “inflammatory bowel disease” [IBD]; IBD is an umbrella term that also includes Crohn’s disease and indeterminate/undifferentiated IBD) Is the initiation of non-invasive dental hygiene procedures* contra-indicated? No Is medical consult advised? ...................................... No (assuming patient/client is already under medical care for ulcerative colitis). Is the initiation of invasive dental hygiene procedures contra-indicated?** Possibly, but not typically Is medical consult advised? ....................................... Possibly (depends on severity and level of control of the disease, including the presence/absence of oral lesions). Is medical clearance required? .................................. Possibly (e.g., if the disease is unstable — flare-up — and/or there are active oral lesions). Also, medical clearance may be required if patient/client is being treated with medications associated with immunosuppression +/- increased risk of infection (e.g., corticosteroids [e.g., prednisone], azathioprine, 6-mercaptopurine, methotrexate, cyclosporine, sulfasalazine, biologic response modifier drugs [e.g., anti-tumour necrosis factor drugs — anti-TNFs — such as infliximab, adalimumab, certoluzimab, and golimumab, as well as monoclonal antibody drugs such as vedoluzimab], JAK1 inhibitors [e.g., tofacitinib], etc.). Is antibiotic prophylaxis required? ............................. -
Mimicry and Deception in Inflammatory Bowel Disease and Intestinal Behçet Disease
Mimicry and Deception in Inflammatory Bowel Disease and Intestinal Behçet Disease Erika L. Grigg, MD, Sunanda Kane, MD, MSPH, and Seymour Katz, MD Dr. Grigg is a Gastroenterology Fellow Abstract: Behçet disease (BD) is a rare, chronic, multisystemic, inflam- at Georgia Health Sciences University in matory disease characterized by recurrent oral aphthous ulcers, genital Augusta, Georgia. Dr. Kane is a Professor ulcers, uveitis, and skin lesions. Intestinal BD occurs in 10–15% of BD of Medicine in the Division of Gastro- patients and shares many clinical characteristics with inflammatory enterology and Hepatology at the Mayo Clinic in Rochester, Minnesota. Dr. Katz bowel disease (IBD), making differentiation of the 2 diseases very diffi- is a Clinical Professor of Medicine at cult and occasionally impossible. The diagnosis of intestinal BD is based Albert Einstein College of Medicine in on clinical findings—as there is no pathognomonic laboratory test—and Great Neck, New York. should be considered in patients who present with abdominal pain, diarrhea, weight loss, and rectal bleeding and who are susceptible to Address correspondence to: intestinal BD. Treatment for intestinal BD is similar to that for IBD, but Dr. Seymour Katz overall prognosis is worse for intestinal BD. Although intestinal BD is Albert Einstein College of Medicine extremely rare in the United States, physicians will increasingly encoun- 1000 Northern Boulevard ter these challenging patients in the future due to increased immigration Great Neck, NY 11021; rates of Asian and Mediterranean populations. Tel: 516-466-2340; Fax: 516-829-6421; E-mail: [email protected] ehçet disease (BD) is a rare, chronic, recurrent, multisys- temic, inflammatory disease that was first described by the Turkish dermatologist Hulusi Behçet in 1937 as a syndrome Bwith oral and genital ulcerations and ocular inflammation.1,2 Prevalence BD is more common and severe in East Asian and Mediter- ranean populations. -
Advice Note: Infant Proctocolitis – Fresh Blood PR in a Thriving Infant
Advice Note: Infant proctocolitis – Fresh blood PR in a thriving infant Dear GP, Thank you for your referral. The most common cause for small amounts of fresh blood PR in a well, thriving infant is infant proctocolitis. This is a benign condition in vast majority of cases and does not require a secondary care input. This is a food protein related reaction most commonly caused by cow’s milk protein (CMP) but other common causes include soy, egg, corn and cereal grains. Rarely other foods can trigger a reaction. Typically infants can tolerate the previously causative proteins by 1 year of age. It does not increase the risk of IgE mediated food allergy. It is common in both breast and formula fed babies. There are no diagnostic tests and the diagnosis relies on exclusion of other causes and resolution of symptoms with dietary manipulations. Features of a typical presentation include: Mucousy loose stools with spots or streaks of bright red blood in a well thriving infant Age at presentation: 1 week to 5 months (although can present earlier and later) It can be associated with mild to moderate diarrhea, excessive crying / fussiness/ sleep disturbance, apparent pain on defecation. It may also be associated with mild anemia, hypoalbuminaemia, mild peripheral eosinophilia and family history of same. Features indicating other disorders include: No IM vitamin K at birth Severe bleeding Abdominal distension / tenderness on examination Faltering growth Signs / symptoms of malabsorption Severe diarrhea Vomiting Anaphylaxis Rash, including petechiae, purpura or urticarial Significant anaemia Persistent perianal dermatitis Anal fissures Management: Referral to ED if the infant : o is unwell and or febrile o is haemodynamically unstable o has a history of severe bleeding o has significant vomiting o has abdominal distension or tenderness on examination o has features of anaphylaxis o has severe anaemia Management in the community if the child is well and there are no worrying features on history or examination: o Investigations: . -
Diagnostic Codes
DISEASES OF THE DIGESTIVE SYSTEM DISEASES OF ORAL CAVITY, SALIVARY GLANDS AND JAWS (520 - 529.9) 520 DISORDERS OF TOOTH DEVELOPMENT AND ERUPTION 520.0 ANODONTIA 520.1 SUPERNUMERARY TEETH 520.2 ABNORMALITIES OF SIZE AND FORM 520.3 MOTTLED TEETH 520.4 DISTURBANCES OF TOOTH FORMATION 520.5 HEREDITARY DISTURBANCES IN TOOTH STRUCTURE, NOT ELSEWHERE CLASSIFIED 520.6 DISTURBANCES IN TOOTH ERUPTION 520.7 TEETHING SYNDROME 520.8 OTHER DISORDERS OF TOOTH DEVELOPMENT 520.9 UNSPECIFIED 521 DISEASES OF HARD TISSUES OF TEETH 521.0 DENTAL CARIES 521.1 EXCESSIVE ATTRITION 521.2 ABRASION 521.3 EROSION 521.4 PATHOLOGICAL RESORPTION 521.5 HYPERCEMENTOSIS 521.6 ANKYLOSIS OF TEETH 521.7 POSTERUPTIVE COLOUR CHANGES 521.8 OTHER DISEASES OF HARD TISSUES OF TEETH 521.9 UNSPECIFIED 522 DISEASES OF PULP AND PERIAPICAL TISSUES 522.0 PULPITIS 522.1 NECROSIS OF THE PULP 522.2 PULP DEGENERATION 522.3 ABNORMAL HARD TISSUE FORMATION IN PULP 522.4 ACUTE APICAL PERIODONTITIS OF PULPAL ORIGIN 522.5 PERIAPICAL ABSCESS WITHOUT SINUS 522.6 CHRONIC APICAL PERIODONTITIS 522.7 PERIAPICAL ABSCESS WITH SINUS 522.8 RADICULAR CYST 522.9 OTHER AND UNSPECIFIED 523 GINGIVAL AND PERIODONTAL DISEASES 523.0 ACUTE GINGIVITIS 523.1 CHRONIC GINGIVITIS 523.2 GINGIVAL RECESSION 523.3 ACUTE PERIODONTITIS 523.4 CHRONIC PERIODONTITIS 523.5 PERIODONTOSIS 523.6 ACCRETIONS ON TEETH 523.8 OTHER PERIODONTAL DISEASES 523.9 UNSPECIFIED 524 DENTOFACIAL ANOMALIES, INCLUDING MALOCCLUSION 524.0 MAJOR ANOMALIES OF JAW SIZE 524.1 ANOMALIES OF RELATIONSHIP OF JAW TO CRANIAL BASE 524.2 ANOMALIES OF DENTAL ARCH -
A Microbiological Study of Non-Gonococcal Proctitis in Passive Male Homosexuals P
Postgrad Med J: first published as 10.1136/pgmj.57.673.705 on 1 November 1981. Downloaded from Postgraduate Medical Journal (November 1981) 57, 705-711 A microbiological study of non-gonococcal proctitis in passive male homosexuals P. E. MUNDAY*t S. G. DAWSONt M.B., M.R.C.O.G. M.B. B.S. A. P. JOHNSON* M. J. OSBORN* B.Sc., Ph.D. H.N.C. B. J. THOMAS* S. PHILIPS B.Sc., Ph.D. F.I.M.L.S. D. J. JEFFRIES§ J. R. W. HARRISt B.Sc., M.B., M.R.C.Path. M.R.C.P., D.T.M.&H. D. TAYLOR-ROBINSON* M.D., F.R.C.Path. *The Sexually Transmitted Diseases Research Group, MRC Clinical Research Centre arrow,o The Praed Street Clinic, St Mary's Hospital, Paddington, and the Departments of$Microbiology and § Virology, St Mary's Hospital Medical School, London copyright. Summary in the rectum producing a proctitis which may or In a study of 180 male homosexual patients attending may not be symptomatic (Fluker et al., 1980). Many a venereal disease clinic, a correlation was sought male homosexuals admitting to passive peno-anal between symptoms and signs of proctitis and the coitus complain of symptoms related to the lower isolation of Neisseria gonorrhoeae, group B strepto- bowel. In addition, asymptomatic patients when cocci, Chlamydia trachomatis, Ureaplasma urea- examined by proctoscopy may be found to have lyticum, Mycoplasma hominis and herpes simplex abnormal signs in the absence of gonococcal infec- http://pmj.bmj.com/ virus. Faecal specimens were examined for enteric tion. -
Ulcerative Proctitis, Rectal Prolapse, and Intestinal Pseudo-Obstruction
0023-6837/01/8103-297$03.00/0 LABORATORY INVESTIGATION Vol. 81, No. 3, p. 297, 2001 Copyright © 2001 by The United States and Canadian Academy of Pathology, Inc. Printed in U.S.A. Ulcerative Proctitis, Rectal Prolapse, and Intestinal Pseudo-Obstruction in Transgenic Mice Overexpressing Hepatocyte Growth Factor/Scatter Factor Hisashi Takayama, Hitoshi Takagi, William J. LaRochelle, Raj P. Kapur, and Glenn Merlino First Department of Internal Medicine (HT, HT), Gunma University School of Medicine, Maebashi, Gunma, Japan; Laboratory of Molecular Biology (GM) and Laboratory of Cellular and Molecular Biology (WJL), National Cancer Institute, Bethesda, Maryland; and Department of Pathology (RPK), University of Washington Medical Center, Seattle, Washington SUMMARY: Hepatocyte growth factor/scatter factor (HGF/SF) can stimulate growth of gastrointestinal epithelial cells in vitro; however, the physiological role of HGF/SF in the digestive tract is poorly understood. To elucidate this in vivo function, mice were analyzed in which an HGF/SF transgene was overexpressed throughout the digestive tract. Nearly a third of all HGF/SF transgenic mice in this study (28 of 87) died by 6 months of age as a result of sporadic intestinal obstruction of unknown etiology. Enteric ganglia were not overtly affected, indicating that the pathogenesis of this intestinal lesion was different from that operating in Hirschsprung’s disease. Transgenic mice also exhibited a rectal inflammatory bowel disease (IBD) with a high incidence of anorectal prolapse. Expression of interleukin-2 was decreased in the transgenic colon, indicating that HGF/SF may influence regulation of the local intestinal immune system within the colon. These results suggest that HGF/SF plays an important role in the development of gastrointestinal paresis and chronic intestinal inflammation. -
The British Society of Gastroenterology
Gut: first published as 10.1136/gut.16.10.821 on 1 October 1975. Downloaded from Gut, 1975, 16, 821-845 The British Society of Gastroenterology The 36th annual meeting was held in Oxford on 25-27 September under the Presidency of Dr S. C. Truelove. The meeting proper was preceded by a teaching day on 24 September when there were two sessions, one on liver disease (Chairman: Dr J. Badenoch), and the other on gastrointestinal disorders (Chairman: Sir Francis Avery Jones). There were 14 sessions each allocated to a different subject, and in addition there was a plenary session and panel discussion on 'The management of ulcerative colitis'. The Sir Arthur Hurst Memorial Lecture, 'Towards an artificial liver', was given on this occasion by Dr Roger Williams. Abstracts of the scientific papers follow and a more general report of the meeting and of the social events can be found on page 846. Distribution of gut hormones monkeys though some variation in total influx mechanism is inhibited by cAMP, amount was seen due to different organ this model also satisfies the paradoxical S. R. BLOOM, M. G. BRYANT, AND J. M. weights. Immunocytochemical data on effect of bile acids in congenital chlor- POLAK (Departments of Medicine and hormone distribution were in substantial idorrhoea. Subsequently, a clinical trial Histochemistry, The Royal Postgraduate agreement. was done. Following oral administration Medical School, Hammersmith Hospital, These hormone maps provide baseline of coated theophylline the frequency and London) Although several new gut hor- data for physiological studies. the volume of the diarrhoeas decreased mones have recently been described there significantly. -
TITLE PAGE "Constipation in Ulcerative Colitis
TITLE PAGE "Constipation in ulcerative colitis - Pathophysiology and Practical Management" Correspondence to Dr Charles Miller, Gastroenterology department, University College London Hospitals NHS foundation Trust, London Gastroenterology department, ground floor, Building 250, Euston Road, London, United Kingdom NW1 2PG, e-mail: [email protected]. Telephone: 0203 447 9126. Professor Anton Emmanuel, University College London Hospitals NHS Foundation Trust and University College London, London, United Kingdom Dr Natalia Zarate-Lopez, University College London Hospitals NHS Foundation Trust, London, United Kingdom. Professor Stuart A Taylor, Consultant Radiologist, UCL Centre For Medical Imaging, Radiology Department, Charles Bell House, 43-45 Foley Street, London, W1W TS. United Kingdom Professor Stuart L Bloom, Consultant Gastroenterologist at UCLH hospitals and honorary Professor of medicine at UCL, Gastroenterology department, University College London Hospitals NHS Foundation Trust. Building 250, Euston road NW1 2PG. United Kingdom. Keywords: Inflammatory bowel disease; ulcerative colitis; constipation Word count: 3298 A CLINCIAL REVIEW: CONSTIPATION IN ULCERATIVE COLITIS Abstract Clinical experience suggests that there is a cohort of patients with refractory colitis who do have faecal stasis that contributes to symptoms. The underlying physiology is poorly understood, partly because until recently the technology to examine segmental colonic motility hasn't existed. Patients are given little information on how proximal faecal